Swiss Biotech Day 2025

Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025, one of Europe’s leading biotechnology partnering and networking events, hosted by the Swiss Biotech Association.

With thousands of industry professionals expected to attend, this year’s event will spotlight innovation across therapeutic areas,
advanced technologies, and international clinical collaboration.

Representing Richmond Pharmacology at Swiss Biotech Day:

• Dr Jörg Täubel, Chief Executive Officer
• Dr Tom Ashdown, Associate Medical Director
• Stephen Wilkinson, Business Development Manager
• Amina Senoussi, Key Account Executive

Our team is looking forward to engaging with global biotech leaders and trial sponsors to explore partnerships in:

• Gene editing and RNA-based therapies
• Rare and ultra-rare disease research
• Innovative regulatory pathways
• Bridging studies
• Patient-first clinical trial delivery

Whether you're advancing a novel therapy or expanding into new regions, we invite you to visit us at Stand 107 to learn how Richmond Pharmacology can support your trial goals.

For meeting requests or collaboration enquiries, please contact:
info@richmondpharmacology.com